摘要
目的探讨国产奥氮平治疗精神分裂症的临床疗效、不良反应。方法将32例符合CCMD-3诊断标准的精神分裂症病人给予国产奥氮平治疗8周,用阳性与阴性症状量表(PANSS)和副反应量表(TESS)评定其疗效和不良反应。结果完成8周治疗的32例精神分裂症病人,基本痊愈9例(28.1%),显进11例(34.4%),进步7例(21.9%),无效5例(15.6%),总有效率为84.4%,不良反应少。结论国产奥氮平治疗精神分裂症安全有效。
Objective To study the clinical efficacy and side effects of the domestic olanzapine in the treatment of schizophrenia. Methods 32 Patients who met CCMD-3 diagnosis criterion for schizophrenia were treated with the domestic olanzapine for 8 weeks, and assessed with Positive and Negative Syndrome Scale （PANSS） and Treatment Emergent Side effect Scale （TESS） for the clinical efficacy and side effects. Results Of 32 cases schizophrenia patients who completed the 8 weeks treatment, 9 cases （28.1% ） were cured, 11 cases （34.4 % ） were markedly improved, 7 cases （21.9 %） were improved and 5 cases （15.6 % ） had no response, Total effective rate was 84.4%, Side effects were slight. Conclusion The study suggests that the domestic olanzapine is effective and safe in the treatment of schizophrenia.
出处
《中国健康心理学杂志》
2008年第7期789-790,共2页
China Journal of Health Psychology
